<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03260478</url>
  </required_header>
  <id_info>
    <org_study_id>MP-20-2018-3706</org_study_id>
    <nct_id>NCT03260478</nct_id>
  </id_info>
  <brief_title>HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial</brief_title>
  <acronym>HEMOTION</acronym>
  <official_title>HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Critical Care Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Traumatic Brain Injury Research Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most trauma deaths are related to traumatic brain injury (TBI). Although the management of
      patients has improved, mortality remains unacceptably high, and half of survivors of moderate
      and severe TBI are left with major functional impairment. Current management guidelines are
      based on limited evidence and practice is highly variable. Most acutely ill patients with TBI
      will develop anemia, which may decrease oxygen delivery to a fragile brain. While clinical
      practice is moving towards transfusing at low hemoglobin (Hb) levels, experts have expressed
      concerns regarding restrictive strategies, which may adversely affect clinical outcomes in
      TBI. Our primary objective is to evaluate the effect of red blood cell (RBC) transfusion
      thresholds on neurological functional outcome. We hypothesize that a liberal transfusion
      strategy improves outcomes compared to a restrictive strategy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Open-label with blinded outcome evaluation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>extended Glasgow Outcome Scale (GOSe)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of neurological outcome by the extended Glasgow Outcome Scale (GOSe)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>ICU, Hospital and at 6 months</time_frame>
    <description>Assessment of patient mortality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Independence Measure (FIM)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of patient function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (EQ-5D)</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of the overall quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (Qolibri questionnaires)</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of the quality of life specific to the TBI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression (PHQ-9)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to work/study of patient</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of patient's return to work/study or comparable previous activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications related to transfusion</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of complications related to RBC transfusions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">712</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Transfusion</condition>
  <arm_group>
    <arm_group_label>Liberal Transfusion Strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive red blood cells transfusion if Hb ≤ 100 g/L.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Restrictive Transfusion Strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive red blood cells transfusion if Hb ≤ 70 g/L.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Red Blood Cells Transfusion</intervention_name>
    <description>Transfusion of packed red blood cells unit(s).</description>
    <arm_group_label>Liberal Transfusion Strategy</arm_group_label>
    <arm_group_label>Restrictive Transfusion Strategy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute moderate to severe blunt TBI

          -  Glasgow Coma Score [GCS] ≤ 12

          -  Hb level ≤ 100 g/L

        Exclusion Criteria:

          -  Patient has received transfusion after ICU admission

          -  Contraindications or known objection to transfusions

          -  Glasgow Coma Scale (GCS) of 3 with dilated fixed pupils.

          -  Patient is brain dead

          -  Active life-threatening bleeding with hemorrhagic shock or requiring urgent surgical
             procedure

          -  A decision to withold or withdraw life-sustaining therapies was made

          -  No fixed address
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Turgeon, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Quebec-Université Laval Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François Lauzier, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Quebec-Université Laval Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dean Fergusson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Hospital Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucy Clayton, MSc</last_name>
    <phone>1 (514) 345-4931</phone>
    <phone_ext>6816</phone_ext>
    <email>Lucy.clayton@recherche-ste-justine.qc.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexis Turgeon, MD MSc FRCPC</last_name>
    <phone>1 (418) 649-0252</phone>
    <email>alexis.turgeon@fmed.ulaval.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foothills Medical Center</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Winnipeg Health Sciences Center</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences Center</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Center</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Research Institute</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Sacré-Coeur de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>McGill University Health Center</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CIUSSS De l'Estrie</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CIUSSS Mauricie-et-Centre-du-Québec</name>
      <address>
        <city>Trois-Rivières</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), Université Laval</name>
      <address>
        <city>Québec</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2017</study_first_submitted>
  <study_first_submitted_qc>August 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2017</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHU de Quebec-Universite Laval</investigator_affiliation>
    <investigator_full_name>Alexis Turgeon</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Traumatic Brain Injury (TBI)</keyword>
  <keyword>Red Blood Cells (RBC) Transfusion</keyword>
  <keyword>Intensive Care Unit (ICU)</keyword>
  <keyword>Transfusion Threshold</keyword>
  <keyword>Anemia</keyword>
  <keyword>Oxygen Delivery</keyword>
  <keyword>Neurocritical Care</keyword>
  <keyword>Critical Care Neurology and Trauma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

